References

  1. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996 Mar; 39(3):343-51. PubMed | Google Scholar

  2. Fattal O, Link J, Quinn K, Cohen BH, Franco K. Psychiatric comorbidity in 36 adults with mithocondrialcytopathies. CNS Spectr. 2007Jun;12(6):429-38. Google Scholar

  3. Kazuno AA, Munakata K, Mori K, Tanaka M, Nanko S,Kunugi H et al. Mithochondrial DNA sequence analysis of patients with 'atypical psychosis'.Psychiatry ClinNeurosci. 2005Aug;59(4):497-503. PubMed | Google Scholar

  4. Kato T. The other, forgotten genome: mitochondrial DNA and mental disorders. Mol Psychiatry. 2001 Nov;6(6): 625-33. PubMed | Google Scholar

  5. Fattal O, Budur K, Vaughan AJ, Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics. 2006 Jan-Feb; 47(1): 1-7. PubMed | Google Scholar

  6. Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implication for the mitochondrial dysfunction hypothesis. Biol Psychiatry. 2009 Mar 15; 65(6):489-494. PubMed | Google Scholar

  7. Kung L, Roberts RC. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse. 1999 Jan; 31(1):67-75. PubMed | Google Scholar

  8. Ben-Shachar D, Laifenfeld D. Mitochondria, synaptic plasticity, and schizophrenia. Int Rev Neurobiol. 2004; 59:273-296. PubMed | Google Scholar

  9. Halim ND, Lipska BK, Hyde TM, Deep-Soboslay A, Saylor EM, Herman MM, Thakar J et al. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. J NeurosciMethods. 2008 Mar 30;169 (1):208-213. PubMed | Google Scholar

  10. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001 Jul 15;55 (5):597-610. PubMed | Google Scholar

  11. Inuwa IM, Peet M, Williams MA. QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenia and treated with antipsychotic drugs. Biotech Histochem. 2005 May-Aug;80 (3-4):133-7. PubMed | Google Scholar

  12. Burkhardt C, Kelly JP, Lim YH, Filley CM, Parker Jr WD. Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol. 1993 May;33 (5):512-7. PubMed | Google Scholar

  13. Prince JA, Yassin MS, Oreland L. A histochemical demonstration of altered cytochrome oxidase activity inthe rat brain by neuroleptics. EurNeuropsychopharmacol. 1998 (Feb);8 (1):1-6. PubMed | Google Scholar

  14. Finsterer J. Psychosis as a manifestation of cerebral involvement in mitochondrial disorders. Recent Adv Clin Med. 2010;. PubMed | Google Scholar